Dasabuvir, ombitasvir, paritaprevir, and ritonavir and MenHibrix

• Generic Name: dasabuvir / ombitasvir / paritaprevir / ritonavir
• Dosage Forms: n.a.
• Other Brand Names: Viekira XR, Viekira Pak

Dasabuvir, ombitasvir, paritaprevir, and ritonavir combination is used with or without ribavirin to treat chronic hepatitis C infection, including patients with compensated cirrhosis.

Dasabuvir, ombitasvir, paritaprevir, and ritonavir is available only with your doctor's prescription.

• Generic Name: haemophilus b conjugate (prp-t) vaccine / meningococcal conjugate vaccine
• Dosage Forms: n.a.
• Other Brand Names: MenHibrix

MenHibrix vaccine is used to help prevent haemophilus B and meningococcal disease in children.

Haemophilus influenzae type B (Hib) is a bacteria that can cause serious illness, including breathing problems or meningitis. Hib infection usually affects children and can be fatal.

Meningococcal disease is a serious infection caused by a bacteria. Meningococcal bacteria can infect the blood, spinal cord, and brain, and can cause meningitis. These conditions can be fatal.

Haemophilus B and meningococcal disease can spread from one person to another through small droplets of saliva that are expelled into the air when an infected person coughs or sneezes. The bacteria can also be passed through contact with objects the infected person has touched, such as a door handle, or other surface. The bacteria can also be passed through kissing, or sharing a drinking glass or eating utensil with an infected person.

MenHibrix works by exposing your child to a small dose of bacteria or a protein from the bacteria, which causes your body to develop immunity to the disease. MenHibrix will not treat an active infection that has already developed in the body.

MenHibrix is for use in children between the ages of 6 weeks and 18 months old.

Like any vaccine, MenHibrix may not provide protection from disease in every person.